NR 293 RUA

NR 293 RUA

Student Name

Chamberlain University

NR-293: Pharmacology for Nursing Practice

Prof. Name:

Date

Medication Teaching Plan for Xtampza ER (Oxycodone)

Overview of Xtampza ER (Oxycodone)

Xtampza ER (oxycodone) is a medication classified as a narcotic analgesic, primarily used for pain management. It works by binding to opiate receptors in the central nervous system (CNS), altering the perception and response to painful stimuli while producing generalized CNS depression (Vallerand, Sanoski, & Quiring, 2019). This therapeutic effect helps to reduce pain levels effectively. In pediatric cases, lower doses may be prescribed: 0.05–0.15 mg/kg every 4–6 hours as needed (Vallerand et al., 2019).

This medication teaching plan is designed to inform patients and caregivers about Xtampza ER’s drug classification, mechanism of action, administration and dosage guidelines, potential drug interactions, lab effects/interference, special considerations, adverse effects/toxicity, patient assessments, and essential patient education.

Key Information for Patients

Patient education is a critical component of the medication plan. Patients must understand the correct timing, route, and dosage of the medication to ensure its safe and effective use. Additionally, due to its known potential for abuse, patients should be advised to take precautions, such as protecting the medication from theft, storing it out of reach of children, and never sharing it with others (Vallerand et al., 2019).

Special considerations for Xtampza ER include its potential harm to a fetus, making it contraindicated during pregnancy. Patients should be counseled on these risks and the importance of adhering to prescribed guidelines to minimize adverse effects and avoid drug misuse.

Features of the Xtampza ER Brochure

The brochure serves as a comprehensive resource for both patients and healthcare providers. It includes the following sections:

1. Drug Class and Mechanism of Action: Explaining how the medication works to manage pain.
2. Administration and Dosage: Guidelines for safe and effective use, including pediatric considerations.
3. Patient Education and Special Considerations: Emphasis on preventing misuse and understanding potential risks, such as fetal harm during pregnancy.

This brochure is written in a clear, easy-to-understand format suitable for non-medical individuals, ensuring accessibility for all audiences.

Table: Medication Teaching Plan for Xtampza ER

References

• Collegium Pharmaceutical, Inc. (n.d.). Xtampza ER – Oxycodone capsule, extended release. Retrieved from https://dailymed.nlm.nih.gov/dailymed

NR 293 RUA

• Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2019). Davis’s drug guide for nurses (16th ed.). Philadelphia, PA: F. A. Davis Company.